Segments
- Hospitals
- Pharma Value Chain (Intermediates, API, Formulations)
- Biopharmaceuticals (Biologics, Biosimilars)
- Outsourcing (CRO, CDMO, CMO)
Transactions
-
Akums drugs &
pharmaceuticals ltd.₹ 1,857 MnIPO Jul 2024
-
Alkem labs₹ 487 MnBlock Aug 2024
-
Emcure pharmaceuticals
ltd.₹ 1,952 MnIPO Jul 2024
-
Alkem labs₹ 990 MnBlock Jun 2024
-
Alkem labs₹ 446 MnBlock Aug 2023
-
Mankind pharma ltd.₹ 4,326 MnIPO Apr 2023
-
Supriya lifesciences ltd₹ 700 MnIPO Dec 2021
-
Medplus health services
ltd₹ 1,398 MnIPO Dec 2021
-
Medplus₹ 5,500 MnFund Raise Dec 2021
-
Supriya lifescience
limited₹ 7,000 MnIPO Dec 2021
-
Medplus health services
limited₹ 13,980 MnIPO Dec 2021
-
Ami organics limited₹ 5,700 MnIPO Sep 2021
-
Chemplast sanmar limited₹ 38,500 MnIPO Aug 2021
-
Clean science and
technology limited₹ 15,470 MnIPO Jul 2021
-
Krishna institute of
medical science ltd₹ 2,144 MnIPO Jun 2021
-
India pesticides limited₹ 8,000 MnIPO Jun 2021
-
Krishna institute of
medical sciences limited₹ 21,440 MnIPO Jun 2021
-
Laxmi organic industries₹ 6,000 MnIPO Mar 2021
Axis Capital’s pharma & healthcare practice is led by
-
Ujjwal Singh Managing DirectorUjjwal leads pharma and healthcare coverage for Axis Capital. He has 19 years of experience in investment banking across M&A, debt, capital markets and private equity financing. He has previously worked with organizations like Avendus, JM Financial, Motilal Oswal and Citibank. Ujjwal has an MBA degr...
Reach out to discover how India’s leading investment bank can help you reach your financial and strategic goals.
